{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:16:08Z","timestamp":1772169368402,"version":"3.50.1"},"reference-count":62,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"j_jpem-2019-0103_s_999\">\n<jats:title id=\"d614445e38807\">Objectives<\/jats:title>\n<jats:p>We aimed to evaluate children with type 1 diabetes (T1D) with early age at onset (EAO) for clinical, immune and metabolic features in order to identify age-related disease phenotypes.<\/jats:p><\/jats:sec>\n<jats:sec id=\"j_jpem-2019-0103_s_998\">\n<jats:title id=\"d614445e38815\">Methods<\/jats:title>\n<jats:p>Comparative study of two groups of T1D children: EAO (\u22645 years) and later age at onset (LAO; &gt;5 years), regarding the presence of other autoimmune (AI) diseases, diabetes ketoacidosis and immunologic profile at onset and metabolic data 1 year after diagnosis. Statistical analysis was performed with significance set for p\u2009&lt;\u20090.05.<\/jats:p><\/jats:sec>\n<jats:sec id=\"j_jpem-2019-0103_s_997\">\n<jats:title id=\"d614445e38823\">Results<\/jats:title>\n<jats:p>The study included 137 children (EAO\u2009=\u200952, mean age 3.6\u2009\u00b1\u20091.5 [mean\u2009\u00b1\u2009standard deviation (SD)] and LAO\u2009=\u200985, mean age 10.4\u2009\u00b1\u20092.9). EAO was more associated with concomitant AI diseases (p\u2009=\u20090.032). Despite no differences in disease onset, EAO presented with lower C-peptide levels (p\u2009=\u20090.01) and higher absolute lymphocyte number (p\u2009&lt;\u20090.0001), with an inverse correlation between these two variables (p\u2009=\u20090.028). Additionally, the EAO group had a higher frequency of serum detection of three antibodies (Abs) (p\u2009=\u20090.0008), specifically insulin Abs (p\u2009=\u20090.0001). One year after diagnosis, EAO had higher total daily insulin (TDI) dose (p\u2009=\u20090.008), despite similar hemoglobin A<jats:sub>1c<\/jats:sub> (HbA<jats:sub>1c<\/jats:sub>).<\/jats:p><\/jats:sec>\n<jats:sec id=\"j_jpem-2019-0103_s_996\">\n<jats:title id=\"d614445e38837\">Conclusions<\/jats:title>\n<jats:p>Our data show an association of EAO T1D with more AI diseases, higher number of Abs, lower initial insulin reservoir and higher insulin requirements 1 year after diagnosis. In this group, immune imbalance seems more evident and disease progression faster, probably reflecting distinct \u201cimmune environment\u201d with different ages at disease onset. Further studies in the field of immunogenetics and immune tolerance are required, to improve patient stratification and find novel targets for therapeutic intervention.<\/jats:p><\/jats:sec>","DOI":"10.1515\/jpem-2019-0103","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T09:03:14Z","timestamp":1562403794000},"page":"935-941","source":"Crossref","is-referenced-by-count":9,"title":["Children with type 1 diabetes of early age at onset \u2013 immune and metabolic phenotypes"],"prefix":"10.1515","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0324-0486","authenticated-orcid":false,"given":"Madalena","family":"Sales Luis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Alcafache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Laura","family":"Fitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-5058","authenticated-orcid":false,"given":"Joana","family":"Sim\u00f5es Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cdris","family":"Caramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Limbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref351","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicenter prospective registration study","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-018-4708-x","article-title":"Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes","volume":"61","year":"2018","journal-title":"Diabetologia"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00125-017-4256-9","article-title":"Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"60","year":"2017","journal-title":"Diabetologia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00005-012-0177-y","article-title":"Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five","volume":"60","year":"2012","journal-title":"Arch Immunol Ther Exp"},{"key":"ref191","first-page":"275","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: other complications and associated conditions in children and adolescents with type 1 diabetes","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"ref291","first-page":"17","article-title":"Role of humoral beta-cell autoimmunity in type 1 diabetes","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"ref401","first-page":"0174840","article-title":"Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"ref491","first-page":"6219730","article-title":"Effect of associated autoimmune diseases on type 1 diabetes mellitus incidence and metabolic control in children and adolescents","volume":"2016","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.1601118","article-title":"Are Tregs defective in type 1 diabetes and can we fix them?","volume":"197","year":"2016","journal-title":"J Immunol"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"012831","DOI":"10.1101\/cshperspect.a012831","article-title":"Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes","volume":"2","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.80.4.367","article-title":"Partial remission phase of diabetes in children younger than age 10 years","volume":"80","year":"1999","journal-title":"Arch Dis Child"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jc.2005-1679","article-title":"Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-018-4708-x","article-title":"Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes","volume":"61","year":"2018","journal-title":"Diabetologia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/pch\/4.1.57","article-title":"The infant and toddler with diabetes: challenges of diagnosis and management","volume":"4","year":"1999","journal-title":"Paediatr Child Health"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-3083.2008.02074.x","article-title":"CD 127\u2212 and FoxP3+ expression on CD25+ CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients","volume":"67","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cei.12672","article-title":"CD4 T cell differentiation in type 1 diabetes","volume":"183","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1900\/RDS.2012.9.148","article-title":"Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease","volume":"9","year":"2012","journal-title":"Rev Diabet Stud"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"012831","DOI":"10.1101\/cshperspect.a012831","article-title":"Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes","volume":"2","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus \u2013 why the \u03b2 cells?","volume":"12","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"ref471","first-page":"20","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: stages of type 1 diabetes in children and adolescents","year":"2018","journal-title":"Pediatr Diabet"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00005-012-0177-y","article-title":"Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five","volume":"60","year":"2012","journal-title":"Arch Immunol Ther Exp"},{"key":"ref511","first-page":"275","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: other complications and associated conditions in children and adolescents with type 1 diabetes","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cei.12672","article-title":"CD4 T cell differentiation in type 1 diabetes","volume":"183","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.retram.2018.01.003","article-title":"Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?","volume":"66","year":"2018","journal-title":"Curr Res Transl Med"},{"key":"ref81","first-page":"0174840","article-title":"Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"ref171","first-page":"6219730","article-title":"Effect of associated autoimmune diseases on type 1 diabetes mellitus incidence and metabolic control in children and adolescents","volume":"2016","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref151","first-page":"20","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: stages of type 1 diabetes in children and adolescents","year":"2018","journal-title":"Pediatr Diabet"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1084\/jem.20082622","article-title":"Causes of early-onset type 1 diabetes: toward data-driven environmental approaches","volume":"205","year":"2008","journal-title":"J Exp Med"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1399-5448.2008.00435.x","article-title":"Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus \u2013 data from a German\/Austrian multicentre survey","volume":"9","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1371\/journal.pone.0001374","article-title":"Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus","volume":"3","year":"2008","journal-title":"PLoS One"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1210\/jc.2002-020018","article-title":"Natural history of \u03b2-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population","volume":"87","year":"2002","journal-title":"Clin Endocrinol Metab"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","year":"2014","journal-title":"Diabetes"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00125-012-2523-3","article-title":"Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk","volume":"55","year":"2012","journal-title":"Diabetologia"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1210\/jc.2002-020018","article-title":"Natural history of \u03b2-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population","volume":"87","year":"2002","journal-title":"Clin Endocrinol Metab"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","article-title":"\u2018The honeymoon phase\u2019 in children with type 1 diabetes mellitus: frequency, duration, and influential factors","volume":"7","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00125-017-4256-9","article-title":"Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"60","year":"2017","journal-title":"Diabetologia"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12020-015-0534-9","article-title":"Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes","volume":"49","year":"2015","journal-title":"Endocrine"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","article-title":"\u2018The honeymoon phase\u2019 in children with type 1 diabetes mellitus: frequency, duration, and influential factors","volume":"7","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jc.2005-1679","article-title":"Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of b-cell destruction and the age at onset of type 1 diabetes","volume":"65","year":"2016","journal-title":"Diabetes"},{"key":"ref611","first-page":"17","article-title":"Role of humoral beta-cell autoimmunity in type 1 diabetes","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.retram.2018.01.003","article-title":"Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?","volume":"66","year":"2018","journal-title":"Curr Res Transl Med"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1399-5448.2008.00435.x","article-title":"Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus \u2013 data from a German\/Austrian multicentre survey","volume":"9","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-3083.2008.02074.x","article-title":"CD 127\u2212 and FoxP3+ expression on CD25+ CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients","volume":"67","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.80.4.367","article-title":"Partial remission phase of diabetes in children younger than age 10 years","volume":"80","year":"1999","journal-title":"Arch Dis Child"},{"key":"ref261","first-page":"1151","article-title":"Clinical presentation and autoimmune characteristics of very young children at the onset of type 1 diabetes mellitus","volume":"23","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40265-015-0511-x","article-title":"Therapies to preserve b-cell function in type 1 diabetes","volume":"76","year":"2016","journal-title":"Drugs"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of b-cell destruction and the age at onset of type 1 diabetes","volume":"65","year":"2016","journal-title":"Diabetes"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1371\/journal.pone.0001374","article-title":"Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus","volume":"3","year":"2008","journal-title":"PLoS One"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1900\/RDS.2012.9.148","article-title":"Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease","volume":"9","year":"2012","journal-title":"Rev Diabet Stud"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","year":"2014","journal-title":"Diabetes"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1084\/jem.20082622","article-title":"Causes of early-onset type 1 diabetes: toward data-driven environmental approaches","volume":"205","year":"2008","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicenter prospective registration study","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/pch\/4.1.57","article-title":"The infant and toddler with diabetes: challenges of diagnosis and management","volume":"4","year":"1999","journal-title":"Paediatr Child Health"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00125-012-2523-3","article-title":"Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk","volume":"55","year":"2012","journal-title":"Diabetologia"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.1601118","article-title":"Are Tregs defective in type 1 diabetes and can we fix them?","volume":"197","year":"2016","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12020-015-0534-9","article-title":"Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes","volume":"49","year":"2015","journal-title":"Endocrine"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40265-015-0511-x","article-title":"Therapies to preserve b-cell function in type 1 diabetes","volume":"76","year":"2016","journal-title":"Drugs"},{"key":"ref581","first-page":"1151","article-title":"Clinical presentation and autoimmune characteristics of very young children at the onset of type 1 diabetes mellitus","volume":"23","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus \u2013 why the \u03b2 cells?","volume":"12","year":"2016","journal-title":"Nat Rev Endocrinol"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2019.32.issue-9\/jpem-2019-0103\/jpem-2019-0103.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:45:45Z","timestamp":1619055945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0103\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":62,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2019-0103","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,25]]}}}